Reader TTS

Some researchers run and hide from the task of authenticating cell lines. A few simple steps save time and money. You have full access to this article via your institution. Download PDF MAIN

Scientists are not easily fooled, but they can unwittingly fool themselves. The identity of a cell line might not be what they assume it is. It is “very risky” for an investigator to begin

a project and spend several years working with a cell line and yet be unsure of its identity, says Karina Eterovic, who directs the characterized cell-line core at MD Anderson Cancer

Center's institute of personalized cancer therapy. Skipping cell-line authentication can lead to lost time, money and publications owing to cross-contamination and misidentification.

Last year, a team had to retract work published in _Nature Methods_ because the cells they studied were contaminated with other cells1. It was not the first case2,3, nor is it likely to be

the last. Researchers should know the true identities of their cell lines. Credit: Thinkstock Eterovic helped colleagues clarify that the widely used KU7 line, derived from bladder cancer

cells, is in fact the HeLa cell line4. The contamination occurred before 1984 at the source institution, which has an effect on all KU7-based experimental results and underscores the impact

of misidentification. Cell-line authentication can seem too time-consuming or daunting. Avoidance and denial behaviors are widespread, say researchers interviewed by _Nature Methods_. They

understand why their colleagues skip essentials to pursue biological questions without delay, but they say it is time to put a few common misconceptions to rest. STANDARDS Some sweet songs

of praise for the scientific community can be heard on the subject of cell-line authentication. There has been “a lot of progress,” says Yvonne Reid, a cell biologist at American Type

Culture Collection (ATCC), a nonprofit biological resource center and repository that offers cell-line authentication services and is active in the area of standards in the life sciences.

Reid has co-authored reports on best practices in cell-line authentication and the recommended standards5. The standards have brought about more change than the numerous warnings and pleas

in past decades, Reid says. The standards are used in many labs and core facilities around the world. Workshops abound on best practices in tissue culture; many journals require

authentication of cell lines, and grant-funding agencies recommend them, all of which makes many researchers optimistic that cell-line misidentification will one day be vanquished—or at

least diminished. That day is not quite nigh. The pollution of labs and scientific literature with misidentified cell lines may well be due to a continued lack of awareness about the extent

of the problem, says Douglas Storts, who directs research and development for nucleic acid research technologies at Promega. He is a co-author with Reid of guidelines on cell-line

authentication5 and was interviewed jointly with her. Among the important resources is the Database of Cross-contaminated or Misidentified Cell Lines6, maintained by the International Cell

Line Authentication Committee (ICLAC), a group founded in 2012 and run by volunteer scientists to establish best practices for the authentication and testing of human cell lines. According

to ICLAC, approximately 400 cell lines are misidentified6. MD Anderson Cancer Center's Karina Eterovic offers in-house repository services for cell lines, including gene-edited ones.

Credit: University of Texas MD Anderson Cancer Center The oldest cell line, HeLa, which is one of the most frequent contaminants of other cell lines, was derived without consent in 1951 from

Henrietta Lacks, who had cervical cancer. The cells and the way they were acquired have been the subject of controversy over the years. Last year, the HeLa genome was sequenced, rekindling

ethics issues because the family had not consented to the sequencing. Meetings between members of the Lacks family and leadership at the US National Institutes of Health (NIH) led to the

establishment of a rule that all publications based on work with HeLa cells acknowledge the Lacks family, who also help to oversee requests to use the genome data. It is still too early to

tell how the discussions about these famous cells are influencing cell-line authentication trends. Having the NIH director address issues relating to cell-line identity is bound to be

helpful, says Reid. The published characterizations of the HeLa cell line show a large number of mutations and rearrangements and help explain why HeLa cells are able to displace other cell

lines, says Storts. PASSAGING Researchers must 'passage' their cells—by changing the growth medium so the cells have fresh nutrients and moving cells to other flasks to maintain

their exponential growth. The longer a cell line is kept in culture, the higher the chances it will acquire genetic changes7. With more passages, genetic drift is more likely, says Reid,

which can lead to dropouts of certain alleles or loss of heterozygosity (Box 1). As cells adapt to environmental conditions they can change so much that they are no longer the cells they

once were, says Darrin Disley, chief executive officer of gene-editing company Horizon, which sells cell lines and offers cell-line repository services for scientists. A lab might send cells

from the same parental cell line to 20 labs. But drift can lead to such large differences that it becomes hard to compare experimental results from these cells. This situation could be

especially likely to arise, Disley says, if the cells were taken from a late-passaged clone that had “just been hanging on for grim life”. Cell culture medium along with many other factors

can also have a role. SHORT TANDEM REPEATS The main test for authenticating cell lines is short tandem repeat (STR) profiling, the analysis of microsatellite regions of DNA that have

variable numbers of repeats and are located throughout the genome. The approach originated with Alec Jeffreys's discovery of variable genomic regions in 1984, and development has

continued since then. STR profiling is the test that most journals require, says Eterovic, and the assay is relatively simple. PCR amplicons are generated using primers for regions that

flank these polymorphic sites. After amplification, PCR products are resolved using capillary electrophoresis, and a profile for these repetitive regions is created. Investigators can do the

analysis on their own, using kits from vendors with primers and reagents for well-known STRs. Buying a kit avoids the need to design primers and optimize PCR reactions, Eterovic says.

Scientists still need a capillary electrophoresis system, which may not be worth the investment if they are only working with a few cell lines. Analyzing these regions is becoming easier

thanks to STR profile databases. “Now individuals can blast against that database and see whether they have misidentified cell lines or not,” says Reid. Cancer cell lines have many mutations

and deletions, so STR analysis requires carefully interpreting the DNA profile report, which presents alleles graphically as peaks. Expert help might be necessary for this analysis, says

Gabriela Saldanha, a marketing manager at Promega, which offers cell-line authentication kits and services. She wonders whether some cell biologists avoid STR analysis because they have less

experience with the molecular biology methods, she says. “Maybe they are not comfortable with having to perform a test themselves.” Scientists at core facilities might help in various ways;

for example, they might be able to do the protocol more quickly, Saldanha says. But they may also leave the interpretation of results up to the scientists, which could pose a challenge for

those unfamiliar with the territory (Box 2). One misconception in some labs is that cell-line authentication calls for an identical STR profile match. But STR profiling looks for an 80%

match or higher in profiled loci, says Donald Finley, Sigma-Aldrich's marketing manager for products relating to _Mycoplasma_. Sigma-Aldrich also sells kits for STR profiling. “With 80%

you can be reasonably confident that you're working with the cell line that you think you're working with,” says Storts. The reason for this 80–100% range is that cell lines can

be unstable owing to a loss of heterozygosity or issues relating to their ploidy. Donald Finley recommends that cell lines are tested regularly for contaminants. Credit: Sigma-Aldrich

According to guidelines published by the American National Standards Institute5, cell lines that match 55–80% of STR loci need further investigation. For many scientists, that broad range

might seem to pose a quandary, says Finley. But it is important to interpret results in that range as inconclusive and to perform further authentication steps before beginning an experiment

with such cells. Eterovic confirms that many types of stresses can result in loss of heterozygosity or lead to genomic rearrangements, which alter an STR profile. The stresses include

extensive passaging, contamination with microorganisms, passage through mice and exposure to drugs. MD Anderson has its own STR database and an algorithm to match STR profiles from unstable

cell lines8. Many users can match their cells' profiles with the help of a public database. But STR results from unstable cell lines or potential mixes of cell lines may also require

special algorithms and interpretation by scientists in a core facility, Eterovic says. _MYCOPLASMA_ Most researchers are aware of potential contamination by _Mycoplasma_ bacteria, but they

probably underestimate its frequency and the degree to which it can influence their experiments, says Andrea Toell, product manager at Lonza Pharma&Biotech Bioscience Solutions. An

estimated 15–35% of cell cultures are contaminated by _Mycoplasma_. “The problem is that you cannot see a contamination just by looking at your cells,” Toell says. _Mycoplasma_ contamination

can affect cell metabolism, increase sensitivity to inducers of apoptosis or inhibit cell growth. From having helped researchers troubleshoot transfection experiments, Toell has seen that

_Mycoplasma_ contamination decreases transfection efficiency. When scientists do not check for potential contamination, “there is always some uncertainty if results gained from an experiment

are really generated by the cells or artificially influenced by _Mycoplasma_,” Toell says. _Mycoplasma_ bacteria are visible only under an electron microscope and they lack cell walls, so

antibiotics may have no effect. Lonza sells a biochemical test that looks for the presence of two enzymes found in the majority of the ∼180 species of _Mycoplasma_. The test does not require

PCR and is performed on cell culture supernatant in around 20 minutes. There are other tests; for example, the most sensitive one, Toell says, is a test in which cell culture supernatant is

plated. _Mycoplasma_ colonies will show up if they were present in the supernatant, but only after 2–3 weeks. PCR-based tests take around 4–5 hours to deliver a result, she says. Non-PCR

approaches involve the use of indicator cells, which gives results within 16–24 hours, or Hoechst staining, which takes about two hours and requires expertise to interpret the results.

Sigma-Aldrich's Finley agrees that using the Hoechst stain, which his company also sells, is “a little tricky.” At the Coriell Institute for Medical Research, cells are kept in ampules

with cryopreservative; scientists practice cell-line authentication on a large scale. Credit: Coriell Institute for Medical Research Many contaminants can kill cell lines, but _Mycoplasma_

is not one of them. _Mycoplasma_ can affect cell performance and render metabolism data or gene-expression results “murky,” Finley says. Sigma-Aldrich sells kits for PCR-based _Mycoplasma_

detection and for cleaning cells of _Mycoplasma_. Overall, Finley recommends that labs set up a regular schedule to test cell lines for contaminants. _Mycoplasma_ is ubiquitous, which is why

aseptic technique is advisable. REPOSITORIES When obtaining cell lines from a repository or vendor, scientists receive a certificate of analysis to show that the cell lines have been

authenticated and are free of contamination, says Finley. A repository can be an in-house facility at a research institute or a separate entity. It can also be organized as a collection of

many repositories under one roof. In the cases of grouped repositories, each distinct collection of biological specimens or cell lines belongs to a different university group, hospital or

company. The Coriell Institute for Medical Research has repositories for government, academic and nonprofit organizations and company labs. For example, they hold the cell lines and DNA of

the US Human Genetic Cell Repository of the National Institute of General Medical Sciences. At Coriell, Dorit Berlin oversees cell-line repositories for several different institutions. She

and her team practice cell-line authentication on a large scale. And, for example, when they culture cells to replenish depleted inventory, they compare the results for loci in the new

expansion to those of the original culture. The team also uses these profile matches to confirm that different cell types attributed to the same donor are from that donor and that

biomaterials collected from the same person but submitted at different times match one another. The tests also look for gender match using PCR-based techniques and a sex-linked gene. To

establish that a cell line is of human origin, the scientists perform a long-interspersed nuclear element (LINE) assay, which is sensitive enough to differentiate human DNA from closely

related chimpanzee DNA, Berlin says. Cell lines are stored in liquid nitrogen, which brings biological activity to a halt. The Coriell Institute for Medical Research ships around 8,000 cell

cultures annually. Credit: Coriell Institute for Medical Research Sigma-Aldrich partners with European Collection of Cell Cultures (ECACC) and sells cell lines that the ECACC has

authenticated. ECACC is a cell and tissue repository run by Public Health England, which is part of the UK Department of Health. “Moving cell lines across borders is difficult,” Finley says.

If a US researcher wants a European cell line, Sigma-Aldrich's distribution agreement will help with cross-border travel. For the cell lines developed at Sigma-Aldrich, such as those

edited with zinc-finger nucleases, the company handles authentication, he says. Using the services of an in-house repository can be more practical for researchers than culturing cell lines

on their own in their lab. At MD Anderson, Eterovic says her core facility offers repository services to expand, profile, store and distribute cell lines developed by in-house investigators,

including gene-edited cell lines. She and her team want to reduce the burden on departments that have interesting cell lines but cannot keep and grow them. In some cases, cell lines need a

home after the original developer leaves the institution. Depositing cell lines with her team helps investigators eliminate the cost of expanding cell lines for requestors, and Eterovic says

she strongly encourages them to do so, preferably at early passages. The core can then expand the cell lines, “but most importantly, it guarantees that the cell line is validated when

requested by another investigator,” she says. GENE EDITING As gene-editing techniques become more widely used, creating cell lines with desired genetic changes is becoming easier. Sharing

these gene-edited cell lines with other labs is good research etiquette, and generally required once the cell line has been reported in a published research article. Researchers should

authenticate cell lines as soon as they receive them but they often do not, says Disley. As a researcher, he has received gene-edited cell lines that, upon authentication, turned out to be

misidentified. The genetic change that the sender said had been edited into the cell line was not present. The originating lab may have passaged the cells too often, leading to genetic

drift. “That's how you end up with a mess across the whole sector,” he says. Starting a research project with a misidentified human cell line and then layering on gene-editing

techniques exacerbates the problem of misidentification, because a lab might launch directly into studying gene function with these cells. “You need a characterized cell line from the

beginning,” says Disley, to analyze follow-on experiments that look at deletions, insertions, substitutions, rearrangements or to be able to credibly perform gain-of-function experiments.

Horizon was originally established to focus on a gene-editing technology that uses adeno-associated viruses to stimulate homologous recombination, but it has now licensed other tools, such

as zinc-finger nucleases or clustered regularly interspaced short palindromic repeats (CRISPR) for gene editing. The company sells cell lines that have been modified with these technologies

and has just begun offering shares on the Alternative Investment Market, a London Stock Exchange market for emerging companies. Scientists who deposit cell lines with the company can land

royalties if these cells find use in drug discovery through Horizon-mediated business. Research with gene-edited cell lines resembles a do-it-yourself project in that both require adequate

preparation, says Disley. One cannot build a chair without the right wood or without knowing whether it will be able to support a certain weight. On the topic of cell-line authentication,

Coriell's Berlin is reminded of something her grandmother used to say: “You can't make gourmet food out of rotten ingredients.” BOX 1: ADVICE FOR THE PASSAGE • Cells must be

transferred from flask to flask so they keep growing. But too much passaging can lead to genetic drift from the parental cell line. • There is no global right or wrong number of passages.

The number varies across cell and tissue types and culture conditions. • Begin with high-quality, authenticated and characterized cells. • Watch the cells carefully. Media and environmental

conditions such as temperature and humidity need to be optimized for cells' well-being. • Growth-curve analysis should be routine to keep track of cell-doubling times. • Freeze batches

of cells at early passages. • Use the lowest-passage aliquot to start fresh cultures. Sources: ATCC; Promega BOX 2: TROUBLESHOOTING STR ANALYSIS • With cancer cell lines it can be difficult

to distinguish low-level STR peaks from noise. Using the recommended amount of DNA can help minimize noise. • Using positive and negative controls helps troubleshoot STR profiles. •

Artifacts may require a repeat of the STR protocol. • 'Stutter peaks' are usually lower than true allele peaks, but using too much DNA can lead to extremely high stutter peaks,

making them harder to distinguish from true allele peaks. • Dye blobs can appear as wide peaks, which the software might assign as regular peaks. The blobs are formed when fluorescent dye

tags detach from their primers. Sometimes this can happen if kits are not stored as vendors recommend. • STR profiling software can identify atypically sized allele microvariants. Vendor

kits might not cover all microvariants. Source: ATCC REFERENCES * Clément, V. et al. _Nat. Methods_ 7, 224–228 (2010); retracted 10, 1035 (2013). Article  Google Scholar  * Gartler, S.M. et

al. _Natl. Cancer Inst. Monogr._ 26, 167–195 (1967). CAS  PubMed  Google Scholar  * Nelson-Rees, W.A. et al. _Science_ 212, 446–452 (1981). Article  CAS  Google Scholar  * Jäger, W. et al.

_J. Urol._ 190, 1404–1409 (2013). Article  Google Scholar  * American Type Culture Collection Standards Development Organization Workgroup. Authentication of human cell lines:

standardization of STR profiling (American National Standards Institute, 2011). * Capes-Davis, A. et al. _Int. J. Cancer_ 127, 1–8 (2010). Article  CAS  Google Scholar  * Masters, J.R. &

Stacey, G.N. _Nat. Protoc._ 2, 2276–2284 (2007). Article  CAS  Google Scholar  * Eltonsy, N. et al. Detection algorithm for the validation of human cell lines. _Int. J. Cancer_ 131,

E1024–E1030 (2012). Article  CAS  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Vivien Marx is technology editor for Nature and Nature Methods, Vivien

Marx Authors * Vivien Marx View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Vivien Marx. RIGHTS AND PERMISSIONS

Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Marx, V. Cell-line authentication demystified. _Nat Methods_ 11, 483–488 (2014). https://doi.org/10.1038/nmeth.2932 Download

citation * Published: 29 April 2014 * Issue Date: May 2014 * DOI: https://doi.org/10.1038/nmeth.2932 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this

content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative